PD0325901

An orally bioavailable, synthetic organic molecule targeting mitogen-activated protein kinase kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity. MEK inhibitor PD325901, a derivative of MEK inhibitor CI-1040, selectively binds to and inhibits MEK, which may result in the inhibition of the phosphorylation and activation of MAPK/ERK and the inhibition of tumor cell proliferation. The dual specific threonine/tyrosine kinase MEK is a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors. (NCI Thesaurus)

YOU MAY ALSO LIKE

PD-168393

A quinazolone compound with anti-tumor activity. PD-168393 is a cell-permeable, irreversible, and selective inhibitor of ligand-dependent epidermal growth factor (EGF) receptor…

PD-1

A protein found on T cells (a type of immune cell) that helps keep the body’s immune responses in check. When PD-1…

PCYT1A wt Allele

Human PCYT1A wild-type allele is located in the vicinity of 3q29 and is approximately 74 kb in length. This allele, which encodes…

PCYT1A Gene

This gene is involved in phosphatidylcholine biosynthesis

PCV Regimen

A regimen consisting of procarbazine, lomustine (CCNU) and vincristine used for the treatment of low grade, adult oligodendroglial tumors.

PCV

An abbreviation for a chemotherapy combination used to treat certain types of brain tumors. It is often used with radiation therapy. It…